Iovance Biotherapeutics has hired Corleen Roche as the biotechnology company's new chief financial officer, effective Aug. 6. Iovance on Tuesday said Roche, 59 years old, most recently served as ...

AI device startup IyO Inc. asked a federal judge to hold Open AI Inc. in civil contempt for “brazenly” violating a temporary ...

The new lawsuit says io co-founder Tang Tan admitted that he received confidential information, including CAD drawings of Iyo’s ear-worn computer, from the startup’s former design and manufacturing ...

The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...

3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking June 29, 2025 — 08:36 am EDT Written by Chris Markoch, MarketBeat Contributor for MarketBeat -> ...

Find out if IO Biotech Inc (IOBT:XNAS) stock is overpriced or undervalued based on Morningstar's evaluation. Assess the current comparison of market prices to the Fair Value of the company's share ...

Stay up to date on how IO Biotech Inc (IOBT:XNAS) stock has performed compared to similar stocks in the same industry on a daily, quarterly, and monthly basis.